Syantra Secures $4.9 Million in Series A-1 Funding; Adds Dr. Rick Mangat to Board of Directors
Syantra secures new funding for expansion and commercialization of its pioneering platform for early detection of cancer
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Syantra secures new funding for expansion and commercialization of its pioneering platform for early detection of cancer
To advance best-in-class neuromodulation therapy for obstructive sleep apnea.
Apheros notes the pre-seed funding round, led by venture capital firm Founderful, will accelerate development and deployment of the companys’ revolutionary metal foam-based cooling solutions.